Levetiracetam Injection (Iv) 100 mg/mL Suppliers & Bulk Manufacturers

Available Forms: Injection (IV)

Available Strengths: 100 mg/mL

Reference Brands: US: Keppra®, Keppra XR®; EU: Keppra®, Levetiracetam Teva®, EpiKeppra®, Zentiva®

Category: Antipsychotropic Drugs

Levetiracetam IV acts by binding to the synaptic vesicle protein SV2A, modulating neurotransmitter release and stabilizing neuronal activity. It is used for treating seizures, including partial-onset, myoclonic, and generalized tonic-clonic seizures. The IV form is ideal for acute seizure management when oral administration is not feasible. Levetiracetam Injection (IV) is FDA-approved in the USA for the treatment of partial-onset, myoclonic, and generalized tonic-clonic seizures in various age groups when oral administration is not possible. It follows strict GMP standards and carries labeling requirements for CNS effects and neuropsychiatric warnings. In the European Union, Levetiracetam IV is approved through centralized or national procedures with emphasis on Risk Management Plans (RMPs) and Periodic Safety Update Reports (PSURs). It must demonstrate bioequivalence for generic versions. Explore high-quality Levetiracetam IV products and global B2B sourcing opportunities at Pharmatradz.com.

Product Description: Levetiracetam, marketed globally under brands like Keppra®, is a widely prescribed anticonvulsant used for treating epilepsy. Available in the US and EU, Levetiracetam comes in oral tablets (250 mg–1000 mg), oral solution (100 mg/mL), and injectable forms. This drug is effective in managing partial, generalized, and myoclonic seizures in adults and children. Its high tolerability and minimal drug interactions make it a preferred option among neurologists. Pharmatradz.com helps you connect with certified global B2B suppliers of Levetiracetam API, formulations, and bulk stock across regulated markets. Source top-quality Levetiracetam from audited manufacturers via Pharmatradz.